Home > Healthcare > Medical Devices > Surgical Devices > Peripheral Interventions Market

Peripheral Interventions Market Trends

Report ID: GMI2915
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Peripheral Interventions Market Trends

Rising technological developments for providing enhanced care and improved treatment results coupled with the higher effectiveness of modern gadgets in non-invasive interventional treatments will provide potential growth opportunities for industry growth. The growing intervention by industry players on heavily investing in improving product innovations to further enhance procedure volumes for boosted product demand and expanded client base will also influence the industry growth. For instance, in February 2023, BIOTRONIK received FDA 510(k) clearance and the CE mark for its Oscar® multipurpose peripheral catheter designed for percutaneous transluminal procedures in the peripheral vascular.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Peripheral interventions industry size was worth USD 8.7 billion in 2022 and is poised to depict over 9% CAGR from 2023-2032 owing to the high prevalence of peripheral artery disease globally.

The catheters product segment is set to grow at 9.3% CAGR from 2023-2032 owing to extensive usage for treatment procedures in hospitalized patients.

North America peripheral interventions industry size is poised to reach over USD 8.1 billion by 2032 attributed to the presence of expanding geriatric patient pool vulnerable to several cardiac disorders in the region

Some of the top peripheral intervention industry players are Biotronik SE & Co. KG, Teleflex Incorporated, Abbott Laboratories, Boston Scientific Corporation, Cook Medical, W. L. Gore & Associates Inc., Cardinal Health Inc., AngioDynamics Inc., Medtronic, and B. Braun Melsungen AG,